NextCure, Inc. (NXTC) – Finance Report
Company Overview
NextCure, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery and development of novel immunomedicines to treat cancer and other immune-related diseases. The company is focused on restoring normal immune function through its immunomedicines. NextCure is headquartered in Beltsville, Maryland and was incorporated in 2015.
Support authors and subscribe to content
This is premium content. Subscribe to read the entire article.